Trial Details
COMPLETEDBasic Information
| Clinical ID | c4381 |
|---|---|
| Identifier | NCT00603616 |
| Trial Title | Induction of Clinical Response Using Rifaximin in Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Placebo Comparator|DRUG: Rifaximin |
Participant Information
| Sponsor | Scott Lee |
|---|---|
| City | Seattle |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2008-11 |
|---|---|
| Primary Completion Date | 2020-11-03 |
| Completion Date | 2020-11-03 |